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This best evidence topic was investigated according to a described protocol. The question posed was:
should the irradiated perineal wound following abdominoperineal resection (APR) be closed with pri-
mary repair or a myocutaneous ﬂap. Using the reported search 364 papers were found of which eight
represented the best evidence to answer the clinical question. The conclusion drawn is that there is some
limited evidence for recommending ﬂap closure in abdominoperineal resection post radiotherapy. The
best evidence available was from a systematic review of cohort studies and case series. Although no
meta-analysis was performed, overall wound healing was improved using ﬂap closure with a low fre-
quency of ﬂap necrosis. Other studies providing evidence were caseecontrol series or cohort studies.
Three papers prospectively compared vertical rectus abdominus muscle (VRAM) ﬂap with primary
closure; two of which demonstrated statistically signiﬁcant improvement in complication rates with ﬂap
closure. Two retrospective case control series showed signiﬁcant improvement in major wound
complication rates in the ﬂap group. Two studies retrospectively compared gracilis ﬂap repair with
primary closure and showed signiﬁcantly lower incidence of major perineal complications.
Most studies suffered from signiﬁcant limitations, small sample sizes and no direct comparisons be-
tween matched groups with respect to type of anatomic ﬂap, wound size, tumour recurrence or radiation
dose. Whilst there is evidence that myocutaneous ﬂap closure following APR in radiotherapy patients can
reduce wound related complications, prospective randomized controlled trials are warranted.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
This best evidence topic was generated according to the struc-
ture outlined in the International Journal of Surgery.12. Clinical scenario
At a regional cancer multi-disciplinary team meeting a
colleague suggests that your irradiated patients undergoing
abdomino-perineal resection (APR) would have better post-
operative wound healing if myocutaneous ﬂap repair was used
instead of primary closure. You decide to assess the evidence base
for this assertion.: þ44 2078867950.
, e.zacharakis@imperial.ac.uk
ciates Ltd. Published by Elsevier Lt3. Three-part question
In [patients undergoing APR with pre-operative radiotherapy],
is [ﬂap repair] or [primary closure] superior in terms of [wound
healing].4. Search strategy
Evidence was searched for using Medline (Pubmed) (1946e12
January 2012): Using the MESH search: (“Perineum”[Mesh]) AND
“Surgical Flaps”[Mesh]. The papers were limited to English lan-
guage and humans. Reference lists were searched for additional
relevant research.5. Search outcome
341 papers were extracted. 108 papers related to other surgical
specialties and 179 were comments, case reports, case series ord. All rights reserved.
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REVIEWtechnical reviews and therefore excluded. 46 papers concerned
either benign colorectal cases or solutions for wound closure other
than myocutaneous ﬂaps. Papers were excluded, if they did
not directly compare primary closure with myocutaneous ﬂap
closure.10,11,12
6. Results
Eight studies provided the highest level of evidence to answer
the question. These are shown in Table 1.
7. Discussion
Nisar et al.2 performed a systematic literature search of peer-
reviewed journals in English relating to anal or rectal oncological
resections and myocutaneous ﬂaps. 36 studies of various method-
ologies were identiﬁed. Five case-controlled studies were identiﬁed
relating to vertical rectus abdominus muscle (VRAM) ﬂaps. Two
case controlled studies were shown using gracilis ﬂaps. The review
also included case series using gluteus maximus ﬂaps. The review
was comprehensive but limited by the calibre of studies available at
the time of the search. No meta-analysis was performed and the
oncological outcomewas not reported. Case series as well as cohort
and case-controls were included. 7 out of 300 patients suffered
total ﬂap loss after VRAM reconstruction and 8 out of 83 suffered
cutaneous necrosis in the gracilis reconstruction group. However
where the groups were controlled, improved overall wound out-
comes were shown for ﬂap repair.
Chan et al.3 undertook a prospective controlled cohort study
comparing 21 patients undergoing abdominoperineal excision
for malignancy who had primary closure with 30 patients who
had a myocutaneous ﬂap repair (24 VRAM, 6 gracilis). The study
was limited in that patients were placed in either group
depending on surgeons’ preference and therefore there were a
higher proportion of patients receiving pre operative chemo-
radiotherapy and a greater number of recurrent cancers in the
ﬂap group (p ¼ 0.011). The study included patients undergoing
total pelvic exenteration and abdominosacral resection. The
study showed no major perineal complications in either group
for unirradiated patients. The ﬂap group had a lower overall rate
of perineal complications however there was a higher rate of
major complications requiring reoperation in the ﬂap group with
a 17% ﬂap necrosis rate. Flap repair had a non-statistically sig-
niﬁcant shorter length of stay. Small sample size, lack of power
calculation and the inclusion of non-irradiated patients in the
control group limit this study.
Chessin et al.4 conducted a prospective cohort study of 19 post
radiotherapy APR patients who underwent VRAM ﬂap repair and
compared them to 59 patients who had primary closure in a his-
torical control group. The groups were matched with respect to
tumour stage. The primary end point waswound healing. The study
showed signiﬁcantly lower rates of perineal wound healing in the
ﬂap group compared with the primary closure group with com-
parable rates of general complications and complications related to
the abdominal wound. In addition all wound complications in the
ﬂap group were minor. Limitations of the study include the bias
related to using a historical control group. In addition patients in
the VRAM ﬂap group had increased factors associated with poor
healing including lower tumour site and operation for tumour
recurrence, however this may actually further support the use of
VRAM ﬂap for high risk patients.
Butler et al.5 retrospectively reviewed a case series of all patients
undergoing APR during a 12-year period and directly compared
VRAM ﬂap repair (35) with primary closure (76). Both groups were
well matched in terms of patient characteristics and tumour stagebut there were more recurrent tumours and anal SCC in the ﬂap
group. The study showed no difference between ﬂap and primary
closure for minor complications including perineal hernia, but
showed signiﬁcantly higher rates of severe complications in the
primary closure group. One patient had complete ﬂap necrosis,
which was reconstructed with gracilis ﬂaps. Abdominal wall com-
plicationswere comparable. No oncological outcomeswere reported.
Radice et al.6 studied 95 patients over a 6-year period who
underwent APR and radiotherapy for locally advanced or recurrent
anorectal cancer. Patients were divided into three groups; primary
closure (20), primary closure with pedicle omental graft (24) or
immediate myocutaneous ﬂap closure (13). Patients in the ﬂap
group had fewer wound complications, so much so that the au-
thor’s practice was modiﬁed to selectively increase the number of
ﬂaps for high dose radiation wounds. 8 patients in the primary
closure groups went on to have conversion to ﬂap repair. The study
was not powered for statistical signiﬁcance and patients groups
were not matched.
Shibata et al.7 retrospectively reviewed 16 patients undergoing
APR post irradiation for recurrent rectal carcinomawho had gracilis
ﬂap closure of the perineum. The wound outcomes were compared
to 24 patients over a similar time period undergoing primary
closure of the perineal wound for similar indications. Patient
characteristics were comparable, however the ﬂap group received
statistically higher doses of radiation. Despite being higher risk-
patients in the ﬂap group had statistically lower incidence of major
complications, deﬁned as major abscesses requiring reoperation.
Risk of minor complications such as persistent perineal sinus tracts
and subcutaneous abscesses were comparable. Limitations of the
study include short follow up- only 6 months with no comment on
abdominal wound complications or perineal herniation.
Persichetti et al.8 conducted a comprehensive study of 10 pa-
tients undergoing APR post neoadjuvant radiotherapy with gracilis
muscle ﬂap closure between 200 and 2005. This case series was
compared to 25 patients who underwent primary repair at an
earlier time 1997e2001, however all resections were performed by
the same surgical team. The patients’ postoperative complications
were reviewed aswell as objectivemarkers of sepsis and blood loss.
Blood loss between the two groups was comparable as were minor
wound dehiscence, perineal hernias and seromas. Major compli-
cations requiring re-operation or persistent infection were statis-
tically higher in the primary closure group.
Lefevre et al.9 retrospectively compared 95 patients who un-
derwent APR for anal squamous cell carcinoma most of who were
post radio-chemotherapy and who had either VRAM ﬂap or pri-
mary closure with omentoplasty. Flap closure patients were
younger, and had more advanced cancer (ypT3-T4 67.6% vs. 38.4%).
Perineal complications were signiﬁcantly reduced in the VRAM
group. Perineal wound dehiscence occurred in the primary closure
group (11.5%) vs. 0 in the VRAM group (p ¼ 0.0214). The rate of
positive surgical margins was higher in the ﬂap group but not
statistically signiﬁcant (26.1% vs.11.5%). 2 patients died within 2/12
post operatively in the VRAM ﬂap group, one due to perineal sepsis.
Long-term survival in the 2 groupswas equivalent despite themore
advanced stage of the VRAM group.
The level of evidence supporting myocutaneous ﬂap repair of
perineum for irradiated patients undergoing APR is consistent.
However all studies have small sample sizes and with distinct
differences between the ﬂap and primary closure groups. For all
study populations there were a greater number of recurrent cancer
cases in the ﬂap group, which will therefore most likely require
more radical excision, which introduces bias when it comes to
assessing wound healing outcomes. In fact these studies show
surgeons practicing ﬂap repair preferentially for higher risk pa-
tients. Not all studies included data on resection margins, or on
Table 1
Papers demonstrating best evidence.
Author, date
and country
of research
Patient group (APR ¼
Abdominoperineal
resection)
Study type and
level of evidence
Outcomes Key results Comments
Nisar PJ
et al.2
2008 UK
36 Trials; including 13
studies comparing primary
closure to ﬂaps.
Combined VRAM ﬂap
closure ¼ 300.
Gracilis ¼ 83.
Systematic
review of
cohort
studies.
Level IIA
Perineal wound
outcomes including
ﬂap necrosis.
No meta-analysis performed.
7/300 ﬂap necrosis (VRAM).
8/83 ﬂap necrosis (gracilis).
Showed consistency in literature for improved
perineal healing rates for myocutaneous ﬂaps
for studies that compared ﬂaps with controls.
Case series and comparisons of different
types of ﬂap with no controls were also
included.
Chan S et al.3
2010 UK
51 patients undergoing
APR.
Primary closure ¼ 21.
Flap closure ¼ 30
(24 VRAM, 6 Gracilis).
Prospective
cohort study.
Level IIIB
Major perineal wound
complications requiring
reoperation.
Length of stay.
Flap necrosis.
Flap ¼ 17%, Primary
closure ¼ 14% (p ¼ 0.65).
Flap ¼ 20 days, Primary
closure ¼ 15 days
(p ¼ 0.36).
17%
Two groups not standardised with respect to
radiotherapy, therefore greater proportion of
irradiated patients in ﬂap group cf with
primary closure group, presumably due to
surgeon’s bias.
Chessin DB
et al.4
2005 USA
78 patients undergoing
APR post radiotherapy.
Primary closure ¼ 59.
Flap closure ¼ 19 (VRAM).
Prospective
cohort study.
Level IIIB.
Perineal wound
complications.
Other complications
including abdominal
wall.
Flap 15.8%, Primary
closure 44.1% (p ¼ 0.03).
Flap 42.1%, Primary closure
42.2% (p ¼ 0.8).
Greater number of patients with anal
squamous tumours, vaginectomy and
recurrence in the ﬂap group. However
overall showed better outcomes for ﬂaps.
Butler CE
et al.5
2008 USA
111 patients undergoing
APR post radiotherapy.
Primary closure ¼ 76, ﬂap
closure ¼ 35 (VRAM).
Retrospective
Case-control
series.
Level IV.
Major complications
(perineal wound/ﬂap
dehiscence)
Minor complications
(Perineal/pelvic ﬂuid
collection requiring
drainage).
Perineal abscess.
Abdominal wall
complication.
Flap 9%, primary 30%
(p ¼ 0.014).
Flap 3%, primary 25%
(p ¼ 0.03).
Flap 9%, primary 37%
(p ¼ 0.002).
No signiﬁcant difference
between two groups.
This retrospective study showed superiority
of ﬂap vs. primary closure in patients post
radiation, with a statistically signiﬁcant
decrease in severe wound complications and
no difference in long term abdominal wall
complications (mean follow up 3.8 years).
Radice E
et al.6
1999 USA
57 patients undergoing
APR.
Primary closure ¼ 20.
Primary closure and
omental pelvic graft ¼ 24.
Flap closure ¼ 13.
Prospective
caseecontrol
series.
Level IV.
Major complications
(requiring reoperation).
Acute (30 day) wound
complications.
Delayed wound healing.
Flap ¼ 0%, Primary
closure ¼ 15%,
omental graft 21%.
Flap ¼ 15% Primary
closure ¼ 35%,
with omental graft 37%.
Flap ¼ 8%, primary
closure ¼ 15%,
omental graft ¼ 25%.
Groups not standardised with respect to
tumour recurrence, with ﬂap group having
more radical surgery and chemo irradiation.
Shibata D
et al.7
1999 USA
40 patients underwent
APR Primary closure ¼ 24.
Flap closure ¼ 16 (Gracilis).
Case-control
series.
Retrospective.
Level IV.
Major complications
(infection requiring
readmission/reoperation).
Minor complications
(sinus, subcutaneous
abscess).
Flap ¼ 12%, primary
closure ¼ 46%;
(p ¼ 0.028).
Flap ¼ 25%, primary
closure ¼ 21%.
This retrospective study showed a possible
advantage of gracilis ﬂap over primary closure
however radiotherapy dose not standardised.
Persichetti P
et al.8
2007 Italy
35 patients undergoing
APR.
Primary closure ¼ 25.
Flap closure ¼ 10 (gracilis).
Case control
series
retrospective
study.
Level IV.
Major complications
(requiring reoperation).
Mild e moderate
complications (seroma,
dehiscence, delayed
healing).
Length of stay.
Flap ¼ 0, primary
closure ¼ 10
(p ¼ 0.03339).
No statistical difference
between the two groups.
No statistical difference.
This study focused on immediate and
short-term postoperative outcomes.
Used objective measures of sepsis: leukocyte
count and temperature.
Lefevre JH
et al.9
2009
France
95 patients underwent
APR for anal cancer.
Primary closure with
omentoplasty ¼ 27.
Flap closure ¼ 42(VRAM).
Case-control
series.
Retrospective.
Level; IV.
Mortality.
Major complication
(requiring re-operation).
Perineal dehiscence.
Minor wound
complications.
5 year survival.
Disease free survival.
Flap ¼ 2 (2.1%), primary
closure ¼ 0 (p ¼ 0.116).
Flap ¼ 25.6%, primary
closure ¼ 17.3%,
(p ¼ 0.3248).
Flap ¼ 0%, primary
closure ¼ 11.5%
(p ¼ 0.0214).
Flap ¼ 26.8%, primary
closure ¼ 44.2%
(p ¼ 0.097).
Flap ¼ 58.1%, primary
closure ¼ 54.4%
(p ¼ 0.6756).
Flap ¼ 41.1%, primary
closure ¼ 48.9%
(p ¼ 0.2756).
Retrospective caseecontrol series. 92% patients
received pre-operative radiotherapy.
Patients receiving ﬂaps were younger with
greater tumour stage and more likely to have
had radiotherapy.
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REVIEWsurvival; which particularly for anal cancer salvage surgery, needs
to be commented upon.13
Another question that these studies do not speciﬁcally address is
how best to close the perineal wound after performing a cylindrical
excision or extra-levator abdomino-perineal excision (ELAPE) in
radical anorectal tumour surgery. One study suggested that this
procedure produces better oncological outcomes for low rectal
tumours however it was associated with increased perineal wound
complications, compared to standard APR. This may be overcome
with the use of myocutaneous ﬂap closure.14 New evidence is
emerging about the beneﬁts of using biological mesh reconstruc-
tion in order to augment closure and prevent perineal herniation
post APR.15,16 There is also work showing the superiority of omental
ﬂap closure.12
Randomised controlled trials to assess the beneﬁts of ﬂap
closure are required. Patients should be stratiﬁed according to
whether they underwent APR, versus ELAPE versus extended
ELAPE. Primary closure versus myocutaneous ﬂap repair and mesh
repair compared to omental ﬂap repair needs to be examined, with
matched control groups with respect to tumour stage and radio-
therapy regimes.
8. Clinical bottom line
With the limited evidence demonstrated thus far; myocuta-
neous ﬂaps can be suggested for irradiated perineal defects; how-
ever which ﬂap is superior and whether there is a role for ﬂap
repairs in non-irradiated or low risk patient groups can not be
determined. The level of evidence is not high enough to demand a
change in practice.
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